Quality Compounder

556 tickers in this investment thesis
Ranks this page's recent reports by score.
Atour Lifestyle Holdings Limited
ATAT·Consumer Discretionary
S ★★★★★Strong Buy
Current$34.87
Target$50.20
Return+44.0%
Aug 26, 2026

Atour Lifestyle runs a high-ROIC ecosystem that turns hotel guests into high-margin e-commerce buyers at a compressed valuation, though investors must monitor Chinese consumer demand amid a domestic economic slowdown.

Score
100
Zai Lab Limited
ZLAB·Healthcare
B ★★★Hold
Current$26.01
Target$39.90
Return+53.4%
Aug 25, 2026

Zai Lab is flawlessly executing a transition from a regional commercialization partner to a global biopharma innovator, supported by a massive cash runway and highly promising proprietary ADCs, though near-term regulatory pricing pressures in China demand a highly cautious, catalyst-driven entry.

Score
83
LeMaitre Vascular, Inc.
LMAT·Healthcare
A ★★★★Buy
Current$81.86
Target$107.00
Return+30.7%
Aug 25, 2026

LeMaitre Vascular is a highly profitable, cash-rich monopoly in the niche peripheral vascular market trading at a generational valuation floor, though investors must tolerate near-term volatility from international regulatory delays and temporary manufacturing consolidation costs.

Score
87
ePlus inc.
PLUS·Technology
B ★★★Hold
Current$86.85
Target$111.00
Return+27.8%
Aug 25, 2026

ePlus is a fundamentally pristine, highly cash-generative IT infrastructure tollbooth successfully pivoting toward high-margin cloud services, but near-term upside remains heavily capped by intense enterprise hardware margin compression and a cautious wave of executive insider selling.

Score
75
Inter & Co, Inc.
INTR·Financials
S ★★★★★Strong Buy
Current$5.39
Target$8.82
Return+63.6%
Aug 25, 2026

Inter is a highly profitable Latin American super app trading at a distressed legacy-bank multiple despite 32% revenue growth and a 16.3% ROE, though investors must monitor non-performing loan volatility tied to Brazil's macro cycle.

Score
98
Vericel Corporation
VCEL·Healthcare
B ★★★Hold
Current$44.26
Target$57.20
Return+29.2%
Aug 25, 2026

Vericel operates a monopolistic, high-margin autologous cell therapy engine transitioning into a cash-generating powerhouse, though its premium valuation requires flawless execution in the MACI Arthro rollout to prevent multiple compression.

Score
76
Digi International Inc.
DGII·Technology
A ★★★★Buy
Current$74.91
Target$93.90
Return+25.4%
Aug 25, 2026

Digi International is moving from cyclical hardware to a sticky, high-margin software ecosystem at a steep discount to software peers, though investors must monitor the balance sheet leverage built up through its aggressive M&A strategy.

Score
92
GCM Grosvenor Inc.
GCMG·Financials
A ★★★★Buy
Current$13.80
Target$16.31
Return+18.2%
Aug 25, 2026

GCM Grosvenor is an established alternative asset manager shifting toward highly profitable direct strategies at a discounted valuation, though investors face concentrated performance-fee risk tied to its large unrealized SpaceX position.

Score
86
Guardian Pharmacy Services, Inc.
GRDN·Healthcare
B ★★★Hold
Current$37.93
Target$43.52
Return+14.7%
Aug 25, 2026

Guardian is a highly profitable, cash-generative tollbooth for the aging ALF population, yet investors should wait for the upcoming Class B share conversion and persistent IRA pricing headwinds to provide a more attractive entry multiple.

Score
76
Alarm.com Holdings, Inc.
ALRM·Technology
A ★★★★Buy
Current$57.51
Target$70.00
Return+21.7%
Aug 25, 2026

Alarm.com operates an elite, cash-gushing B2B SaaS monopoly in the professional smart property sector trading at a deep historical discount, successfully utilizing explosive commercial and energy software growth to entirely outrun the structural headwinds of ADT's transition and macroeconomic hardware tariff volatility.

Score
86
A10 Networks, Inc.
ATEN·Technology
B ★★★Hold
Current$26.12
Target$38.40
Return+47.0%
Aug 25, 2026

A10 Networks is a highly profitable, cash-gushing tollbooth for the global AI infrastructure buildout, executing flawless margin expansion and capital returns, though investors must remain hyper-vigilant regarding its extreme revenue concentration with Microsoft and historically stretched valuation multiples.

Score
79
BJ's Wholesale Club Holdings, Inc.
BJ·Consumer Staples
A ★★★★Buy
Current$96.42
Target$115.00
Return+19.3%
Aug 24, 2026

BJ's is a highly profitable, cash-gushing warehouse club trading at an unjustifiable discount to its peers, though investors must monitor whether its aggressive expansion into Costco-dominated territories can maintain the high margins recently subsidized by a volatile fuel environment.

Score
91